PT Itama Ranoraya Tbk (IDX:IRRA)

Market Cap	563.92B -20.8%
Revenue (ttm)	1.10T +3.1%
Net Income	65.90B +11.2%
EPS	42.68 +8.6%
Shares Out	1.51B
PE Ratio	8.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	762,300
Open	374.00
Previous Close	374.00
Day's Range	370.00 - 376.00
52-Week Range	322.00 - 615.00
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About PT Itama Ranoraya Tbk

PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. It offers in vitro diagnostics products comprising rapid test, serology, glucose diagnostic, NAPZA test, and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; nefrology, blood and transfusion, orthopedic, radiotherapy, and surgical products; and hospital supplies and hospital kitchen equipment. The company also p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1988
• Employees: 209
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: IRRA

Financial Performance

In 2025, PT Itama Ranoraya Tbk's revenue was 1.10 trillion, an increase of 12.55% compared to the previous year's 977.49 billion. Earnings were 65.53 billion, an increase of 23.03%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 15, 2026

Data Sources Report a data error